NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Timing of ctDNA Testing in Advanced Breast Cancer

RecruitingN/A

Sponsor: Geneplus-Beijing Co. Ltd.

Conditions: Advanced Breast Cancer

Countries: China

This multicenter, prospective observational cohort study aims to investigate the impact of circulating tumor DNA (ctDNA) level and key actionable gene mutation status on prognosis and treatment response in patients with advanced breast cancer.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Histologically confirmed advanced breast cancer
* Age ≥18 years
* Expected survival \>3 months
* Willing to undergo ctDNA testing and sign informed consent form

Exclusion Criteria:

* The subject has not signed the informed consent form.
* Pregnant or breastfeeding women.
* Other situations deemed by the investigator as unsuitable for inclusion in the study.

Locations (1)

Beijing, China